Staging of non-small cell lung cancer: Imaging of intrathoracic disease

European Journal of Radiology

Volumn 45, Issue 1, 2003, Pages 18-30

  MacDonald, Sharyn L S ^a   Hansell, David M ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Computed tomography (CT); Lung cancer; Neoplasm staging

Indexed keywords

CELLS; IMAGING TECHNIQUES; PULMONARY DISEASES;

COMPLEMENTARY IMAGING TECHNIQUE; NON-SMALL CELL LUNG CANCER;

RADIOLOGY;

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; IMAGING SYSTEM; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MEDIASTINUM; PERICARDIAL EFFUSION; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX WALL; ULTRASOUND;

EID: 0037214246     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(02)00300-5     Document Type: Article

References (100)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
2. Belli L., Meroni A., Rondianara G., et al. Bronchoplastic procedures and pulmonary artery reconstruction in the treatment of bronchogenic cancer. J. Thorac. Cardiovasc. Surg. 90:1985;167-171.
3. Mountain C.F. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer. 73:1994;2589-2598.
4. Martini N., Kris M.G., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa(N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann. Thorac. Surg. 55:1993;1365-1374.
5. Rusch V.W., Albain K.S., Crowley J.J., et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. J. Thorac. Cardiovasc. Surg. 105:1993;97-106.
6. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J. Thorac. Cardiovasc. Surg. 96:1988;440-447.
7. Epstein D.M., Stephenson L.W., Gefter W.B., et al. Value of CT in the preoperative assessment of lung cancer: a survey of thoracic surgeons. Radiology. 161:1986;423-427.
8. Lahde S., Paivansalo M., Rainio P. CT for predicting the resectability of lung cancer: a prospective study. Acta Radiol. 32:1991;449-454.
9. Lewis J.W., Pearlberg J.L., Beute G.H., et al. Can computed tomography of the chest stage lung cancer? Yes and no. Ann. Thorac. Surg. 49:1990;591-596.
10. Quint L.E., Glazer G.M., Orringer M.B. Central lung masses: prediction with CT of need for pneumonectomy versus lobectomy. Radiology. 165:1987;735-738.
11. Gay S.B., Black W.B., Armstrong P., et al. Chest CT of unresectable lung cancer. RadioGraphics. 8:1988;735-748.
12. Primack S.L., Lee K.S., Logan P.M., Miller R.R., Muller N.L. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology. 193:1994;795-800.
13. Martini N., Heelan R., Westcott J., et al. Comparative merits of conventional computed tomograpic and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J. Thorac. Cardiovasc. Surg. 90:1985;639-648.
14. White P.G., Adams H., Crane M.D., et al. Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours? Thorax. 49:1994;951-957.
15. Glazer H.S., Kaiser L.R., Anderson D.J., et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology. 173:1989;37-42.
16. Scott I.R., Muller N.L., Miller R.R., et al. Resectable stage III lung cancer: CT, surgical and pathologic correlation. Radiology. 166:1988;75-79.
17. Musset D., Grenier P., Carette M.F., et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology. 160:1986;607-611.
18. Stiglbauer R., Schurawitzki H., Klepetko W. Contrast-enhanced MRI for the staging of bronchogenic carcinoma: comparison with CT and histopathologic staging - preliminary results. Clin. Radiol. 44:1991;293-298.
19. Mayr B., Lenhard M., Fink U., et al. Preoperative evaluation of bronchogenic carcinoma: value of MR in T- and N-staging. Eur. J. Radiol. 14:1992;245-251.
20. Webb W.R., Gatsonis C., Zerhouni E.A., et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 178:1991;705-713.
21. Gefter W.B. Magnetic resonance imaging in the evaluation of lung cancer. Semin. Roentgenol. 25:1990;73-84.
22. Haramati L.B., White C.S. MR imaging of lung cancer. MRI Clin. N. Am. 8:2000;43-57.
23. Piehler J.M., Pairolero P.C., Weiland L.H., et al. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en-bloc resection. Ann. Thorac. Surg. 34:1982;684-691.
24. McCaughan B.C., Martini N., Bains M.S., et al. Chest wall invasion of carcinoma of the lung: therapeutic and prognostic implications. J. Thorac. Cardiovasc. Surg. 89:1985;836-841.
25. Ratto G.B., Piacenza G., Frola C., et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann. Thorac. Surg. 51:1991;182-188.
26. Allen M.S., Mathisen D.J., Grillo H.C., et al. Bronchogenic carcinoma with chest wall invasion. Ann. Thorac. Surg. 51:1991;948-951.
27. McLoud T.C., Swensen S.J. Lung carcinoma. Clin. Chest Med. 20:1999;697-713.
28. Quint L.E., Francis I.R., Wahl R.L., Gross B.H., Glazer G.M. Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. Am. J. Roentgenol. 164:1995;1349-1359.
29. Pennes D.R., Glazer G.M., Wimbish K.J., et al. Chest wall invasion by lung cancer: limitations of CT evaluation. Am. J. Roentgenol. 144:1985;507-511.
30. Glazer H.S., Duncan-Meyer J., Aronberg D.J., et al. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology. 157:1985;191-194.
31. Pearlberg J.L., Sandler M.A., Beute G.H. Limitations of CT in evaluation of neoplasms involving chest wall. J. Comput. Assist. Tomogr. 11:1987;290-293.
32. Webb W.R., Jeffrey R.B., Godwin J.D. Thoracic computed tomography in superior sulcus tumors. J. Comput. Assist. Tomogr. 5:1981;361-365.
33. O'Connell R.S., McLoud T.C., Wilkins E.W. Superior sulcus tumor: radiographic diagnosis and workup. Am. J. Roentgenol. 140:1983;25-30.
34. Heelan R.T., Demas B.E., Caravelli J.F., et al. Superior sulcus tumors: CT and MR imaging. Radiology. 170:1989;637-641.
35. McLoud T.C., Filion R.B., Edelman R.R., Shepard J.O. MR imaging of superior sulcus carcinoma. J. Comput. Assist. Tomogr. 13:1989;233-239.
36. Freundlich I.M., Chasen M.H., Varma D.G.K. Magnetic resonance imaging of pulmonary apical tumors. J. Thorac. Imaging. 11:1996;210-222.
37. Takasugi J.E., Rapoport S., Shaw C. Superior sulcus tumors: the role of imaging. J. Thorac. Imaging. 4:1989;41-48.
38. Hanson J.A., Armstrong P. Staging intrathoracic non-small-cell lung cancer. Eur. Radiol. 7:1997;161-172.
39. Remy-Jardin M., Duyck P., Remy J., et al. Hilar lymph nodes: identification with spiral CT and histologic correlation. Radiology. 196:1995;387-394.
40. Genereux G.P., Howie J.L. Normal mediastinal lymph node size and number: CT and anatomic study. Am. J. Roentgenol. 142:1984;1095-1100.
41. Quint L.E., Glazer G.M., Orringer M.B. Mediastinal lymph node detection and sizing at CT and autopsy. Am. J. Roentgenol. 147:1986;469-472.
42. Libshitz H.I., McKenna R.J. Jr. Mediastinal lymph node size in lung cancer. Am. J. Roentgenol. 143:1984;713-718.
43. Kerr K.M., Lamb D., Wathen C.G., Walker W.S., Douglas N.J. Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax. 47:1992;337-341.
44. McLoud T.C., Bourgouin P.M., Greenberg R.W., et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 182:1992;319-323.
45. Arita T., Kuramitsu T., Kawamura M., et al. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax. 50:1995;1267-1269.
46. Gross B.H., Glazer G.M., Orringer M.B., Spizarny D.L., Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology. 166:1988;71-74.
47. Grenier P., Dubray B., Carette M.F., et al. Pre-operative thoracic staging of lung cancer: CT and MR evaluation. Diagn. Interv. Radiol. 1:1989;23.
48. Glazer G.M., Orringer M.B., Chenevert T.L., et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology. 168:1988;429-431.
49. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 111:1997;1718-1723.
50. Tisi G.M., Friedman P.J., Peters R.M., et al. Clinical staging of primary lung cancer: official statement of the American Thoracic Society. Am. Rev. Respir. Dis. 127:1983;659.
51. Pearson F.G., DeLarue N.G., Ilves R., Todd T.R.J., Cooper J.D. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J. Thorac. Cardiovasc. Surg. 83:1982;1-11.
52. Goldstraw P., Mannam G.C., Kaplan D.K., Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J. Thorac. Cardiovasc. Surg. 107:1994;19-27.
53. Vansteenkiste J.F., De Leyn P.R., Deneffe G.J., et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann. Thorac. Surg. 63:1997;1441-1450.
54. Conces D.J., Klink J.F., Tarver R.D., Moak G.D. T1N0M0 lung cancer: evaluation with CT. Radiology. 170:1989;643-646.
55. Heavey L.R., Glazer G.M., Gross B.H., Francis I.R., Orringer M.B. The role of CT in staging radiographic T1N0M0 lung cancer. Am. J. Roentgenol. 146:1986;285-290.
56. Pearlberg J.L., Sandler M.A., Beute G.H., Madrazo B.L. T1N0M0 bronchogenic carcinoma: assessment by CT. Radiology. 157:1985;187-190.
57. Daly B.D., Faling L.J., Bite G., et al. Mediastinal lymph node evaluation by computed tomography in lung cancer. An analysis of 345 patients grouped by TNM staging, tumor size, and tumor location. J. Thorac. Cardiovasc. Surg. 94:1987;664-672.
58. Becker G.L., Whitlock W.L., Schaefer P.S., Tenholder M.F. The impact of thoracic computed tomography in clinically staged T1, N0, M0 chest lesions. Arch. Intern. Med. 150:1990;557-559.
59. Seely J.M., Mayo J.R., Miller R.R., Muller N.L. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology. 186:1993;129-132.
60. Parker L.A., Mauro A., Delany D.J., King C.W. Evaluation of T1 N0 M0 lung cancer with CT. J. Comput. Assist. Tomogr. 15:1991;943-947.
61. Duncan K.A., Gomersall L.N., Weir J. Computed tomography of the chest in T1N0M0 non-small cell bronchial carcinoma. Br. J. Radiol. 66:1993;20-22.
62. Sahn S.A. Pleural effusion in lung cancer. Clin. Chest Med. 14:1993;189-200.
63. Decker D.A., Dines D.E., Payne W.S., et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest. 74:1978;640-642.
64. Patz E.F., Erasmus J.J., McAdams H.P., et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced CT of the thorax. Radiology. 1999;56-60.
65. Quint L.E., Francis I.R. Radiologic staging of lung cancer. J. Thorac. Imaging. 14:1999;235-246.
66. Silvestri G.A., Littenberg B., Colice G.L. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am. J. Respir. Crit. Care Med. 152:1995;225-230.
67. Onitsuka H., Tsukada M., Araki A., et al. Differentiation of central lung tumour from post-obstructive lobar collapse by rapid sequence computed tomography. J. Thorac. Imaging. 6:1991;28-31.
68. Muller N.L., Fraser R.S., Colman N.C., Pare P.D. Radiologic diagnosis of diseases of the chest. 1st ed: 2001;229-232 W.B. Saunders Company, Philadelphia.
69. Haramati L.B., Cartagena A.M., Austin J.H.M. CT evaluation of mediastinal lymphandenopathy: non-contrast 5 mm vs. post-contrast 10 mm sections. J. Comput. Assist. Tomogr. 19:1995;375-378.
70. Shimoyama K., Murata K., Takahashi M., et al. Pulmonary hilar lymph node metastases from lung cancer: evaluation based on morphology at thin section, incremental, dynamic CT. Radiology. 203:1997;187-195.
71. Storto M.L., Ciccotosto C., Guidotti A., et al. Neoplastic extension across pulmonary fissures: value of spiral computed tomography and multiplanar reformations. J. Thorac. Imaging. 13:1998;204-205.
72. Watanabe A., Shimokata K., Saka H., et al. Chest CT combined with artificial pneumothorax: value in determining origin and extent of tumor. Am. J. Roentgenol. 156:1991;707-710.
73. Murata K., Takahashi M., Mori M., et al. Chest wall and mediastinal invasion by lung cancer: evaluation with multisection expiratory dynamic CT. Radiology. 191:1994;251-255.
74. Ohtsuka T., Minami M., Nakajima J., et al. Cine computed tomography for evaluation of tumours invasive to the thoracic aorta: seven clinical experiences. J. Thorac. Cardiovasc. Surg. 112:1996;190-192.
75. Yokoi T., Mori K., Miyazawa N., et al. Tumor invasion of the chest wall and mediastinum in lung cancer: evaluation with pneumothorax CT. Radiology. 181:1991;147-152.
76. Nolop K.B., Rhodes C.G., Brudin L.H., et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer. 60:1987;2682-2689.
77. Duhaylongsod F.G., Lowe V.J., Patz E., et al. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann. Thorac. Surg. 60:1995;1348-1352.
78. Pieterman R.M., van Putten J.W.G., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with 18-fluorodeoxyglucose positron-emission tomography. N. Engl. J. Med. 343:2000;254-261.
79. Lewis P.J., Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J. Nucl. Med. 35:1994;1647-1649.
80. Lewis P., Griffin S., Marsden P., et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 344:1994;1265-1266.
81. Guhlmann A., Storck M., Kotzerke J., et al. Lymph node staging in non-small cell lung cancer: evaluation by [18]FDG positron emission tomography (PET). Thorax. 52:1997;438-441.
82. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest. 112:1997;1480-1486.
83. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J. Clin. Oncol. 16:1998;2142-2149.
84. Steinert H., Hauser M., Allemann F., et al. Non-small cell lung cancer: nodal sampling with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 202:1997;441-446.
85. Wahl R.L., Quint L.E., Greenough R.L., et al. Staging of mediastinal non-small cell lung cancer with FDG-PET, CT and fusion images: preliminary prospective evaluation. Radiology. 191:1994;371-377.
86. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology. 213:1999;530-536.
87. Gambhir S.S., Hoh C.K., Phelps M.E., Madar I., Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J. Nucl. Med. 37:1996;1428-1436.
88. Dietlein M., Weber K., Gandjour A., et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small-cell lung cancer: priority for a PET-based strategy after nodal-negative results. Eur. J. Nucl. Med. 27:2000;1598-1609.
89. Laking G., Price P. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer. Thorax. 56:2001;ii38-ii44.
90. Sazon D.A., Santiago S.M., Soo Hoo G.W., et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am. J. Respir. Crit. Care Med. 153:1996;417-421.
91. Chin R., Ward R., Keyes J.W., et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am. J. Respir. Crit. Care Med. 152:1995;2090-2096.
92. Patz E.F., Lowe V.J., Goodman P.C., et al. Thoracic nodal staging with PET imaging with 18 FDG in patients with bronchogenic carcinoma. Chest. 108:1995;1617-1621.
93. Scott W.J., Gobar L.S., Terry J.D., et al. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J. Thorac. Cardiovasc. Surg. 111:1996;642-648.
94. Gress F.G., Savides T.J., Sandler A., et al. Endoscopic ultrasonography, fine needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study. Ann. Intern. Med. 127:1997;604-612.
95. Silvestri G.A., Hoffman B.J., Bhutani M.S., et al. Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer. Ann. Thorac. Surg. 61:1996;1441-1446.
96. Hawes R.H., Gress F., Kesler K., et al. Endoscopic ultrasound versus computed tomography in the evaluation of the mediastinum in patients with non-small-cell lung cancer. Endoscopy. 26:1994;784-787.
97. Williams D.B., Sahai A.V., Aabakken L., et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single center experience. Gut. 44:1999;720-726.
98. Hunerbein M., Ghadimi B.M., Haensch W., et al. Transoesphageal biopsy of mediastinal and pulmonary tumors by means of endoscopic guidance. J. Thorac. Cardiovasc. Surg. 116:1998;554-559.
99. Penman I., Fergusson R.J. Endoscopic ultrasound: a useful tool to assess the mediastinum in patients with lung cancer? Thorax. 57:2002;95-96.
100. Wiersema M.J., Edell E.S., Midthun D.E., et al. A blinded prospective study comparing transbronchial needle aspiration (TBNA) and endosonography guided needle aspiration (EUS FNA) in the staging of mediastinal lymphadenopathy in patients with non small cell lung cancer. Gastrointest. Endosc. 53:2001;AB556.